Allergan takes Linzess on a run with differentiation push

Carly Helfand

Every drugmaker wants to find differentiators for their products. And for Ironwood, it was obvious. "Is this a constipation drug that improves abdominal symptoms, or is this an abdominal pain drug that improves constipation?" chief commercial officer Tom McCourt first asked company R&D chief Mark Currie.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS